Pre- and postradical cystectomy tumor-informed ctDNA dynamics is a powerful predictor of oncological outcomes: those who convert from detectable to undetectable ctDNA fare worse than those staying undetectable
@ReubenBenDavid1@MehrazinMD@DrJohnSfakianos
https://t.co/DMg9UxALNT
Online now: The use of 99mTc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot study
@cpavmd @michael_gorin@BasilKaufmann
https://t.co/o1HBeBv8qQ
Thrilled on our lastest publication in European Urology Oncology!
ctDNA may revolutionize the way we choose treatment modalities for patients with bladder cancer.
Paving our way in adding the letter G-for genomic to TNM staging, adding another layer of clarity to our patients.
https://t.co/9GGmuVzR8l
@DrJohnSfakianos@MehrazinMD@NDTillu@IcahnMountSinai@MountsinaiUro
Just published: Focal Therapy with High-Intensity Focused Ultrasound for #ProstateCancer: Three Year Outcomes from a Prospective Trial by @BasilKaufmann@michael_gorin@deberli and colleagues
https://t.co/8RbIbHBejl
Excited to share preprint of our first foray into using LLMs to augment urologic research / medicine more broadly. Amazing work by @BasilKaufmann and phenomenal mentorship by @AshTewariMD @ @MMenonMD. See what @OpenAI GPT can do for research!! https://t.co/2Tf1Co34Bl